Diagnostic Approach to Low C3 and Fanconi Syndrome

Primary Diagnostic Consideration: Monoclonal Gammopathy

The combination of low C3 and Fanconi syndrome most strongly suggests monoclonal gammopathy of renal significance (MGRS), particularly light chain-mediated proximal tubulopathy with concurrent immune complex glomerulonephritis or C3 glomerulopathy, according to the American Society of Nephrology 1, 2
Monoclonal gammopathy is the leading cause to investigate when low C3 and Fanconi syndrome coexist in adults, especially in patients over 50 years old, as recommended by the International Society of Nephrology 1, 2
The same monoclonal protein can trigger complement dysregulation leading to low C3 through immune complex formation or alternative pathway activation, as stated by the European Renal Association 1, 2

Serum and urine protein electrophoresis with immunofixation must be performed immediately, as suggested by the National Kidney Foundation 1, 2
Serum free light chain analysis is essential for detecting monoclonal proteins, according to the American Association of Clinical Chemistry 2
Kidney biopsy with pronase digestion of paraffin-embedded tissue is critical, as standard immunofluorescence may miss masked monoclonal deposits in up to 5-10% of cases, as recommended by the Renal Pathology Society 2
Immunofluorescence studies must include staining for IgG, IgM, IgA, C1q, C3, and κ and λ light chains, as stated by the International Society of Nephrology 1

Bacterial infections, particularly invasive pneumococcal disease, can cause both low C3 (through classical pathway activation) and Fanconi-like syndrome simultaneously, as reported by the Infectious Diseases Society of America 3, 2
Post-infectious glomerulonephritis classically presents with low C3 that should normalize by 8-12 weeks; persistently low C3 beyond this timeframe suggests C3 glomerulopathy rather than infection-related disease, according to the American Society of Nephrology 3, 2
Endocarditis and shunt nephritis can present with low complement and concurrent tubular dysfunction, as stated by the European Society of Cardiology 3

Serum complement levels: C3, C4, CH50 to determine pathway activation pattern, as recommended by the Clinical and Laboratory Standards Institute 2
Low C3 with normal C4 suggests alternative pathway activation (C3 glomerulopathy); low C3 and low C4 suggest classical pathway activation (immune complex disease), according to the American College of Rheumatology 5, 2
Complete urinalysis with sediment evaluation for dysmorphic hematuria and red blood cell casts, as suggested by the National Kidney Foundation 2
24-hour urine protein quantification (significant if >500 mg/day), urine electrolytes, glucose, amino acids, phosphate, uric acid, and β2-microglobulin, as recommended by the International Society of Nephrology 1, 4

Serum and urine protein electrophoresis with immunofixation, as suggested by the American Association of Clinical Chemistry 1, 2
Serum free light chain analysis, according to the International Myeloma Society 2
Blood and urine cultures if infection is suspected, as recommended by the Infectious Diseases Society of America 3

Kidney biopsy is advised given the presence of Fanconi syndrome (hypouricaemia) combined with low C3 suggesting glomerular disease, as stated by the Renal Pathology Society 1
Light microscopy with Congo red staining, immunofluorescence (including IgG subtyping if heavy chains are IgG), and electron microscopy are mandatory, according to the International Society of Nephrology 1
Pronase digestion of paraffin-embedded tissue must be performed if monoclonal gammopathy is detected or suspected to unmask hidden monoclonal deposits, as recommended by the American Society of Nephrology 2

Do not assume infection-related glomerulonephritis if C3 remains low beyond 12 weeks; this mandates evaluation for C3 glomerulopathy or monoclonal gammopathy, as stated by the American College of Physicians 3, 2
Do not rely solely on standard immunofluorescence in patients over 50 years old, as 60-80% may have monoclonal gammopathy requiring pronase digestion to detect masked deposits, according to the International Society of Nephrology 2
Do not overlook active infections as triggers for complement dysregulation in genetically susceptible patients; treat the infection before labeling as primary autoimmune disease, as recommended by the Infectious Diseases Society of America 2
Do not delay kidney biopsy in the setting of declining renal function, as early diagnosis of MGRS-related lesions is critical for targeted therapy, as stated by the National Kidney Foundation 1